Risks for stroke and bleeding with warfarin or aspirin treatment in patients with atrial fibrillation at different CHA 2 DS 2 VASc scores: experience from the Stockholm region
Conclusions
The present observations confirm earlier findings of undertreatment with warfarin and half of the high-risk patients treated with aspirin were obvious candidates for anticoagulant treatment. However, the other half of the patients had complicating co-morbidities, high bleeding risk, and poor prognosis. This and possible overtreatment of low-risk patients should be taken into account when considering more aggressive use of anticoagulant treatment.
Source: European Journal of Clinical Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Aspirin | Atrial Fibrillation | Bleeding | Coumadin | Drugs & Pharmacology | Ischemic Stroke | Primary Care | Stroke | Study | Warfarin